At Retina Society 2026, Eileen Hwang, MD, PhD, discusses a meta-analysis finding a 1.78 times higher retinal detachment rate ...
Concurrent exudative disease, early intervention, and a rare masquerader complicate the classic picture of geographic atrophy ...
Reem Amine, MD, a postdoctoral research fellow at Duke Eye Center in Durham, North Carolina, discusses her findings, what ...
Charles Wykoff, MD, PhD, reviews LUGANO safety and treatment burden data, including a 42% injection reduction with vorolanib ...
Three residents were honored for their leadership, education and research, and patient care contributions in ophthalmology, ...
Jesse L. Berry, MD, discusses prospective data on aqueous humor liquid biopsy in retinoblastoma and explains how molecular markers from the aqueous are beginning to guide recurrence risk, treatment ...
In this episode of The Retina TL;DR with Dr. Weng, powered by Modern Retina, host Christina Y. Weng, MD, MBA, FASRS, professor and the Alice R. McPherson Retina Research Foundatio ...
Patient enrollment is complete in the the ASTRA phase 3 study AURN001 to treat corneal edema associated with corneal ...
Breazzano, MD, FACS, shares findings from a TriNetX real-world database analysis on how HIV co-infection influences RPR ...
The alternative pathway ratios Ba/Factor B (0.350, 95% CrI: 0.021 to 0.644), and Bb/Factor B (0.203, 95% CrI: -0.086 to 0.475 ...
The phase 2 ArMaDa results showed that one subretinal injection of medium-dose OCU410, an investigational adeno-associated ...
Chhablani reports revakinagene taroretcel-lwey slowed cavitation volume growth and preserved photoreceptor structure in MacTel type 2.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results